NSE
HALEOS LABS LIMITEDHALEOSLABS
HALEOS LABS LIMITED is a leading developer of innovative pharmaceuticals and vaccines in India.
| Key products | Vaccines, Pharmaceuticals |
|---|---|
| Geography | India, Middle East, Africa |
| Competitors | Dr. Reddy's Laboratories, Cipla Limited |
AI-generated overview β verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 Β· tilt Neutral
Next corporate action
Dividend - Rs 1.50 Per Share
ex 2025-09-24
| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +βΉ41.3 Cr | 331 | β | β | β | β |
| 2 | ATALREAL | +βΉ5 Cr | 372 | β | β | β | β |
| 3 | GATECH | +βΉ0.4 Cr | 298 | β | β | β | β |
| 4 | HALEOSLABSThis | +βΉ0 Cr | 1 | β | β | β | β |
| 5 | IRMENERGY | ββΉ2.2 Cr | 356 | β | β | β | β |
| 6 | QUADFUTURE | ββΉ9 Cr | 581 | β | β | β | β |
| 7 | MOBIKWIK | ββΉ150.9 Cr | 975 | β | β | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-16FilingHALEOS LABS LIMITED has informed the Exchange regarding 'Transfer Of Shares (IEPF Suspense Account)'.Updates
- 2026-06-12FilingTVVSN Murthy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and EShareholding Disclosure
- 2025-12-16BulkSELL Β· βΉ2 CrBHARADHWAJAN JAGANATHAN VELAMUR
- 2025-12-16NetDay net ββΉ2 Cr
- 2025-09-24ActionDividend - Rs 1.50 Per ShareDividend
- 2024-09-23ActionAnnual General Meeting/Dividend - Rs 1.50 Per ShareDividend
Merged from deals, filings, corporate actions and news β newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF β
1 deals Β· 2025-12-16 β 2025-12-16
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-12-16 | BHARADHWAJAN JAGANATHAN VELAMUR | HNI / other | SELL | βΉ2 Cr |
1 deal in the selected window β corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on HALEOSLABS
RSS News
0No recent news.
Google News RSS β links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.